ArticleAesthetic plastic surgery2026
Surgical Management of Unilateral Labia Minora Hypertrophy: A Retrospective Clinical Study of Individualized Reduction Techniques.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundUnilateral labia minora hypertrophy (ULMH) presents unique surgical challenges, primarily in achieving strict bilateral symmetry and preserving neurovascular integrity while using the contralateral normal side as a reference. Traditional techniques often fail to address the specific morphologic nuances required for individualized unilateral reconstruction.
objectivesThis study aimed to evaluate the clinical efficacy, aesthetic outcomes, and safety of a refined surgical approach-the mucosal advancement flap combined with a de-epithelialized mucosal flap specifically tailored for ULMH.
methodsA retrospective review was conducted on 46 consecutive patients with ULMH treated between January 2020 and December 2025. The surgical design utilized "opposilateral reference calibration," where the dimensions and contour of the unaffected labium served as a dynamic template. Precise tissue reduction was achieved by combining superior/inferior mucosal advancement with central de-epithelialization to protect the main neurovascular bundles. Outcomes were assessed via labial width measurements, complication rates, and patient satisfaction using a 5-point Likert scale.
resultsThe mean labial width decreased significantly from 29.72±5.18 mm preoperatively to 7.78±1.75 mm at the 3-month follow-up (P<0.0001). Primary wound healing was achieved in 45 cases (97.8%), with only one case of delayed healing and no instances of hematoma, infection, or permanent sensory loss. The overall satisfaction rate was 100%, with patients reporting significant improvements in aesthetic symmetry, functional comfort, and psychosexual confidence.
conclusionsThe individualized mucosal advancement and de-epithelialization technique is a safe and highly effective strategy for ULMH. By prioritizing anatomical mirroring and neurovascular preservation, this approach ensures superior bilateral symmetry and natural aesthetic contours.\ LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42443419What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.